Literature DB >> 29688812

Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease.

Morgan G Stykel1, Kayla Humphries1, Mathew P Kirby1, Chris Czaniecki1, Tinya Wang1, Tammy Ryan1, Vladimir Bamm1, Scott D Ryan1,2.   

Abstract

Neuronal loss in Parkinson's disease (PD) is associated with aberrant mitochondrial function in dopaminergic (DA) neurons of the substantia nigra pars compacta. An association has been reported between PD onset and exposure to mitochondrial toxins, including the agrochemicals paraquat (PQ), maneb (MB), and rotenone (Rot). Here, with the use of a patient-derived stem cell model of PD, allowing comparison of DA neurons harboring a mutation in the α-synuclein (α-syn) gene ( SNCA-A53T) against isogenic, mutation-corrected controls, we describe a novel mechanism whereby NO, generated from SNCA-A53T mutant neurons exposed to Rot or PQ/MB, inhibits anterograde mitochondrial transport through nitration of α-tubulin (α-Tub). Nitration of α-Tub inhibited the association of both α-syn and the mitochondrial motor protein kinesin 5B with the microtubules, arresting anterograde transport. This was, in part, a result of nitration of α-Tub in the C-terminal domain. These effects were rescued by inhibiting NO synthesis with the NOS inhibitor Nω-nitro-L-arginine methyl ester. Collectively, our results are the first to demonstrate a gene by environment interaction in PD, whereby agrochemical exposure selectively triggers a deficit in mitochondrial transport by nitrating the microtubules in neurons harboring the SNCA-A53T mutation.-Stykel, M. G., Humphries, K., Kirby, M. P., Czaniecki, C., Wang, T., Ryan, T., Bamm, V., Ryan, S. D. Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease.

Entities:  

Keywords:  anterograde transport; isogenic hiPSCs; neurodegeneration; reactive nitrogen species; tubulin nitration

Mesh:

Substances:

Year:  2018        PMID: 29688812     DOI: 10.1096/fj.201700759RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

1.  Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.

Authors:  Christopher Czaniecki; Tammy Ryan; Morgan G Stykel; Jennifer Drolet; Juliane Heide; Ryan Hallam; Shalandra Wood; Carla Coackley; Keith Sherriff; Craig D C Bailey; Scott D Ryan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

Review 2.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 3.  Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis.

Authors:  Michaela E Johnson; Benjamin Stecher; Viviane Labrie; Lena Brundin; Patrik Brundin
Journal:  Trends Neurosci       Date:  2018-10-17       Impact factor: 13.837

Review 4.  Cellular models of alpha-synuclein toxicity and aggregation.

Authors:  Marion Delenclos; Jeremy D Burgess; Agaristi Lamprokostopoulou; Tiago F Outeiro; Kostas Vekrellis; Pamela J McLean
Journal:  J Neurochem       Date:  2019-07-30       Impact factor: 5.372

5.  Docosahexanoic acid signals through the Nrf2-Nqo1 pathway to maintain redox balance and promote neurite outgrowth.

Authors:  Jennifer Drolet; Brodie Buchner-Duby; Morgan G Stykel; Carla Coackley; Jing X Kang; David W L Ma; Scott D Ryan
Journal:  Mol Biol Cell       Date:  2021-01-27       Impact factor: 4.138

6.  A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity.

Authors:  Vignayanandam Ravindernath Muddapu; Alekhya Mandali; V Srinivasa Chakravarthy; Srikanth Ramaswamy
Journal:  Front Neural Circuits       Date:  2019-02-25       Impact factor: 3.492

7.  GardeninA confers neuroprotection against environmental toxin in a Drosophila model of Parkinson's disease.

Authors:  Urmila Maitra; Thomas Harding; Qiaoli Liang; Lukasz Ciesla
Journal:  Commun Biol       Date:  2021-02-05

Review 8.  Modelling Parkinson's Disease: iPSCs towards Better Understanding of Human Pathology.

Authors:  Sahar Avazzadeh; Jara Maria Baena; Cameron Keighron; Yajaira Feller-Sanchez; Leo R Quinlan
Journal:  Brain Sci       Date:  2021-03-14

Review 9.  Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models.

Authors:  Angeliki Spathopoulou; Frank Edenhofer; Lisa Fellner
Journal:  Front Neurol       Date:  2022-01-25       Impact factor: 4.003

10.  Calycosin Alleviates Paraquat-Induced Neurodegeneration by Improving Mitochondrial Functions and Regulating Autophagy in a Drosophila Model of Parkinson's Disease.

Authors:  Hitesh Singh Chaouhan; Xin Li; Kuo-Ting Sun; I-Kuan Wang; Tung-Min Yu; Shao-Hua Yu; Kuen-Bao Chen; Wei-Yong Lin; Chi-Yuan Li
Journal:  Antioxidants (Basel)       Date:  2022-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.